SCHEMBL5280577

SCHEMBL5280577

O=C(O)CC(c1ccccc1)n1cnc2ccc(NC(=O)C3Cc4ccccc4N3)cc21

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 3/20 0.35
ALDH1A1 P00352 3/20 0.35
ITGB3 P05106 5/20 0.34
ITGA2B P08514 4/20 0.34
LMNA P02545 3/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ITGAV P06756 2/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
NOTUM Q6P988 1/20 0.32
FLT3 P36888 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5301973 0.93 RAB9A (0.40) MAPTGAARAB9AALDH1A1ITGB3
SCHEMBL5306255 0.85 ALDH1A1 (0.37) MAPTGAARAB9AALDH1A1ITGB3
SCHEMBL5284712 0.83 POLB (0.43) ITGB3ITGA2BITGAVSMN1; SMN2
SCHEMBL5280316 0.82 GHSR (0.47) RAB9AALDH1A1LMNANPC1SMN1; SMN2
SCHEMBL2292264 0.78 NPC1 (0.44) MAPTRAB9AALDH1A1LMNANPC1
SCHEMBL2292578 0.77 KDM4E (0.44) MAPTRAB9AALDH1A1LMNANPC1
SCHEMBL2294478 0.77 NPC1 (0.48) MAPTRAB9ALMNANPC1SMN1; SMN2
SCHEMBL5285256 0.77 TP53 (0.48) MAPTGAARAB9AALDH1A1LMNA
SCHEMBL2294191 0.77 NPC1 (0.38) MAPTGAARAB9ALMNACYP3A4
SCHEMBL5295212 0.77 POLB (0.43) RAB9ALMNANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828144-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed